Skip to main content
. 2019 Jun 1;40(21):1670. doi: 10.1093/eurheartj/ehz349

Figure 1.

Figure 1

Impact of biologic treatment on psoriasis and coronary artery disease. (Upper panel) Psoriasis patient before (left) and after (right) treatment with biologic agent demonstrates resolution of skin disease. (Lower panel) Representative coronary computed tomography angiography images of left anterior descending artery in a psoriasis patient. This patient had a low attenuation high-risk lipid-rich coronary plaque in the mid-left anterior descending artery before treatment with biologic treatment (left two images and upper image in the middle panel). Low attenuation plaque improves post-biologic therapy as seen in the lower image in the middle panel along with the two images on the right.